{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:28:18Z","timestamp":1790224098130,"version":"4.1.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/2021\/002419"],"award-info":[{"award-number":["CRG\/2021\/002419"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.autrev.2024.103515","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T18:21:18Z","timestamp":1704478878000},"page":"103515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Animal models unraveling the complexity of vitiligo pathogenesis"],"prefix":"10.1016","volume":"23","author":[{"given":"Prashant","family":"Giri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharm","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitesh","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2024.103515_bb0005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0749.2006.00355.x","article-title":"The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force","volume":"20","author":"Ta\u00efeb","year":"2007","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.autrev.2024.103515_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000506103","article-title":"Vitiligo: a review","volume":"236","author":"Bergqvist","year":"2020","journal-title":"Dermatology"},{"key":"10.1016\/j.autrev.2024.103515_bb0015","doi-asserted-by":"crossref","first-page":"473","DOI":"10.4103\/ijd.IJD_822_19","article-title":"A nationwide, multicentric case\u2013control study on vitiligo (MEDEC-V) to elicit the magnitude and correlates","volume":"65","author":"Sarma","year":"2020","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.autrev.2024.103515_bb0020","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-immunol-100919-023531","article-title":"Vitiligo: mechanisms of pathogenesis and treatment","volume":"38","author":"Frisoli","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2024.103515_bb0025","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1600-0749.2005.00242.x","article-title":"Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo","volume":"18","author":"Laberge","year":"2005","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.autrev.2024.103515_bb0030","first-page":"10","article-title":"Vitiligo: a review of aetiology, pathogenesis, treatment, and psychosocial impact","author":"AL-smadi","year":"2023","journal-title":"Cosmetics"},{"key":"10.1016\/j.autrev.2024.103515_bb0035","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1038\/jid.2015.92","article-title":"A new view of vitiligo: looking at normal-appearing skin","volume":"135","author":"Picardo","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2024.103515_bb0040","first-page":"189","article-title":"Microorganisms in pathogenesis and management of vitiligo","author":"Giri","year":"2022","journal-title":"Role Microorg Pathog Manag Autoimmune Dis"},{"key":"10.1016\/j.autrev.2024.103515_bb0045","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1755-148X.2012.00997.x","article-title":"Revised classification\/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference","volume":"25","author":"Ezzedine","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.autrev.2024.103515_bb0050","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.3389\/fimmu.2020.624566","article-title":"A concise review on the role of endoplasmic reticulum stress in the development of autoimmunity in vitiligo pathogenesis","volume":"11","author":"Jadeja","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103515_bb0055","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.coi.2013.10.010","article-title":"Innate immune mechanisms in vitiligo: danger from within","volume":"25","author":"Richmond","year":"2013","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.autrev.2024.103515_bb0060","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1590\/abd1806-4841.20186068","article-title":"Macrophage migration inhibitory factor as an incriminating agent in vitiligo","volume":"93","author":"Farag","year":"2018","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.autrev.2024.103515_bb0065","doi-asserted-by":"crossref","first-page":"6952299","DOI":"10.1155\/2022\/6952299","article-title":"Meta-analysis of alterations in regulatory T Cells\u2019 frequency and suppressive capacity in patients with vitiligo","volume":"2022","author":"Giri","year":"2022","journal-title":"J Immunol Res"},{"key":"10.1016\/j.autrev.2024.103515_bb0070","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/pcmr.12105","article-title":"Decreased regulatory T-cells and CD4(+) \/CD8(+) ratio correlate with disease onset and progression in patients with generalized vitiligo","volume":"26","author":"Dwivedi","year":"2013","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.autrev.2024.103515_bb0075","first-page":"7","article-title":"Global activation of CD8+ cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligo","author":"Lili","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2024.103515_bb0080","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/bjd.13511","article-title":"Alteration in regulatory T cells and programmed cell death 1-expressing regulatory T cells in active generalized vitiligo and their clinical correlation","volume":"172","author":"Tembhre","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2024.103515_bb0085","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/pcmr.12862","article-title":"Altered expression of nuclear factor of activated T cells, forkhead box P3, and immune-suppressive genes in regulatory T cells of generalized vitiligo patients","volume":"33","author":"Giri","year":"2020","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.autrev.2024.103515_bb0090","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/exd.14157","article-title":"Decreased suppression of CD8+ and CD4+ T cells by peripheral regulatory T cells in generalized vitiligo due to reduced NFATC1 and FOXP3 proteins","volume":"29","author":"Giri","year":"2020","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.autrev.2024.103515_bb0095","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/imm.13538","article-title":"Calcium controlled NFATc1 activation enhances suppressive capacity of regulatory T cells isolated from generalized vitiligo patients","volume":"167","author":"Giri","year":"2022","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2024.103515_bb0100","doi-asserted-by":"crossref","first-page":"3426717","DOI":"10.1155\/2022\/3426717","article-title":"Decreased GZMB, NRP1, ITPR1, and SERPINB9 transcripts lead to reduced regulatory T cells suppressive capacity in generalized vitiligo patients","volume":"2022","author":"Giri","year":"2022","journal-title":"J Immunol Res"},{"key":"10.1016\/j.autrev.2024.103515_bb0105","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.autrev.2014.10.002","article-title":"Regulatory T cells in vitiligo: implications for pathogenesis and therapeutics","volume":"14","author":"Dwivedi","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2024.103515_bb0110","first-page":"1","article-title":"Viral causes of vitiligo: a new perspective for vitiligo pathogenesis","volume":"2","author":"Dwivedi","year":"2018","journal-title":"Viral Immunol"},{"key":"10.1016\/j.autrev.2024.103515_bb0115","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/bjd.12467","article-title":"Association of NLRP1 genetic variants and mRNA overexpression with generalized vitiligo and disease activity in a Gujarat population","volume":"169","author":"Dwivedi","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2024.103515_bb0120","doi-asserted-by":"crossref","first-page":"e107020","DOI":"10.1371\/journal.pone.0107020","article-title":"Association of neuropeptide Y (NPY), interleukin-1B (IL1B) genetic variants and correlation of IL1B transcript levels with vitiligo susceptibility","volume":"9","author":"Laddha","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2024.103515_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.613056","article-title":"Targeting innate immunity to combat cutaneous stress: the vitiligo perspective","volume":"12","author":"Boniface","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103515_bb0130","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.0022-202X.2005.23653.x","article-title":"4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: relevance to vitiligo","volume":"124","author":"Kroll","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2024.103515_bb0135","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/s41467-019-09963-8","article-title":"Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo","volume":"10","author":"Tulic","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2024.103515_bb0140","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1701698","article-title":"Antigen-induced but not innate memory CD8 T cells express NKG2D and are recruited to the lung parenchyma upon viral infection","volume":"200","author":"Grau","year":"2018","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2024.103515_bb0145","article-title":"Altered regulatory T cell-mediated Natural Killer cells suppression may lead to generalized vitiligo","author":"Giri","year":"2023","journal-title":"Hum Immunol"},{"key":"10.1016\/j.autrev.2024.103515_bb0150","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00403-019-01996-9","article-title":"Predominant role of innate pro-inflammatory cytokines in vitiligo disease","volume":"312","author":"Gholijani","year":"2020","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.autrev.2024.103515_bb0155","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s40257-013-0039-3","article-title":"The role of tumor necrosis factor-\u03b1 in the pathogenesis of vitiligo","volume":"14","author":"Camara-Lemarroy","year":"2013","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.autrev.2024.103515_bb0160","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/bjd.14016","article-title":"Tumour necrosis factor-\u03b1 inhibition can stabilize disease in progressive vitiligo","volume":"173","author":"Webb","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2024.103515_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2021.146027","article-title":"Meta-analysis for association of TNFA-308(G > A) SNP with vitiligo susceptibility","volume":"809","author":"Giri","year":"2022","journal-title":"Gene"},{"key":"10.1016\/j.autrev.2024.103515_bb0170","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/exd.12372","article-title":"Role of oxidative stress and autoimmunity in onset and progression of vitiligo","volume":"23","author":"Laddha","year":"2014","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.autrev.2024.103515_bb0175","article-title":"Immunophenotypic analysis reveals differences in circulating immune cells in the peripheral blood of patients with segmental and nonsegmental vitiligo","author":"Willemsen","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2024.103515_bb0180","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/1523-1747.ep12461505","article-title":"Evidence for immunologic mechanisms in human vitiligo: patients\u2019 sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity","volume":"90","author":"Norris","year":"1988","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2024.103515_bb0185","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1002\/1097-0142(19931015)72:8<2365::AID-CNCR2820720812>3.0.CO;2-G","article-title":"Vitiligo autoantibodies are effective against melanoma","volume":"72","author":"Fishman","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.autrev.2024.103515_bb0190","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/labinvest.3700438","article-title":"Function-blocking autoantibodies to the melanin-concentrating hormone receptor in vitiligo patients","volume":"86","author":"Gottumukkala","year":"2006","journal-title":"Lab Invest"},{"key":"10.1016\/j.autrev.2024.103515_bb0195","first-page":"20","article-title":"Emerging role of tissue resident memory T cells in vitiligo: from pathogenesis to therapeutics","author":"Shah","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2024.103515_bb0200","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/cei.12146","article-title":"Melanocyte-specific CD8+ T cells are associated with epidermal depigmentation in a novel mouse model of vitiligo","volume":"174","author":"You","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2024.103515_bb0205","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.177.5.3055","article-title":"CD4 T cell-dependent autoimmunity against a melanocyte neoantigen induces spontaneous vitiligo and depends upon Fas-Fas ligand interactions","volume":"177","author":"Lambe","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2024.103515_bb0210","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1046\/j.1365-2249.2002.01949.x","article-title":"Autoantibodies in vitiligo patients are not directed to the melanocyte differentiation antigen MelanA\/MART1","volume":"129","author":"Waterman","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2024.103515_bb0215","first-page":"417","article-title":"The role of NKG2D in vitiligo","volume":"12","author":"Plaza-Rojas","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103515_bb0220","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/jid.2011.463","article-title":"A mouse model of vitiligo with focused epidermal depigmentation requires IFN-\u03b3 for autoreactive CD8+ T-cell accumulation in the skin","volume":"132","author":"Harris","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2024.103515_bb0225","first-page":"S16","article-title":"The role of the Th1 chemokine CXCL10 in vitiligo","volume":"3","author":"Antonelli","year":"2015","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.autrev.2024.103515_bb0230","first-page":"1","article-title":"Autoimmune factors in the ethiopathogenesis of vitiligo","author":"Skudar","year":"2015","journal-title":"MOJ Anat Physiol"},{"key":"10.1016\/j.autrev.2024.103515_bb0235","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/bjd.14416","article-title":"Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo","volume":"174","author":"Wang","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2024.103515_bb0240","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/pcmr.12355","article-title":"Increased circulating Th17 cells and elevated serum levels of TGF-beta and IL-21 are correlated with human non-segmental vitiligo development","volume":"28","author":"Zhou","year":"2015","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.autrev.2024.103515_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2023.147629","article-title":"Genetic association of nuclear factor of activated T cells\u2019 3\u2019UTR and structural polymorphisms with susceptibility to generalized vitiligo in Gujarat population","volume":"880","author":"Giri","year":"2023","journal-title":"Gene"},{"key":"10.1016\/j.autrev.2024.103515_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.111174","article-title":"Harmine and Kaempferol treatment enhances NFATC1 and FOXP3 mediated regulatory T-cells\u2019 suppressive capacity in generalized vitiligo","volume":"125","author":"Giri","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.autrev.2024.103515_bb0255","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/pcmr.12284","article-title":"Immune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentation","volume":"27","author":"Eby","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.autrev.2024.103515_bb0260","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/jid.2013.540","article-title":"A quantitative increase in regulatory T cells controls development of vitiligo","volume":"134","author":"Chatterjee","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2024.103515_bb0265","first-page":"11","article-title":"Antigen specificity enhances disease control by tregs in vitiligo","author":"Mukhatayev","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103515_bb0270","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/med.21754","article-title":"Mechanisms of melanocyte death in vitiligo","volume":"41","author":"Chen","year":"2021","journal-title":"Med Res Rev"},{"key":"10.1016\/j.autrev.2024.103515_bb0275","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.dsi.2014.09.008","article-title":"Animal models of vitiligo: matching the model to the question","volume":"32","author":"Essien","year":"2014","journal-title":"Dermatol Sin"},{"key":"10.1016\/j.autrev.2024.103515_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.145295","article-title":"Association of FOXP3 and GAGE10 promoter polymorphisms and decreased FOXP3 expression in regulatory T cells with susceptibility to generalized vitiligo in Gujarat population","volume":"768","author":"Giri","year":"2021","journal-title":"Gene"},{"key":"10.1016\/j.autrev.2024.103515_bb0285","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1365-2133.2012.11000.x","article-title":"Interleukin-4 genetic variants correlate with its transcript and protein levels in patients with vitiligo","volume":"167","author":"Imran","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2024.103515_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180958","article-title":"A case-control study on association of proteasome subunit beta 8 (PSMB8) and transporter associated with antigen processing 1 (TAP1) polymorphisms and their transcript levels in vitiligo from Gujarat","volume":"12","author":"Jadeja","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2024.103515_bb0295","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1089\/jir.2012.0171","article-title":"Involvement of interferon-gamma genetic variants and intercellular adhesion molecule-1 in onset and progression of generalized vitiligo","volume":"33","author":"Dwivedi","year":"2013","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.autrev.2024.103515_bb0300","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/1346-8138.12147","article-title":"Modern vitiligo genetics sheds new light on an ancient disease","volume":"40","author":"Spritz","year":"2013","journal-title":"J Dermatol"},{"key":"10.1016\/j.autrev.2024.103515_bb0305","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nature05660","article-title":"Melanocyte biology and skin pigmentation","volume":"445","author":"Lin","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2024.103515_bb0310","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1755-148X.2010.00803.x","article-title":"The cell biology of human hair follicle pigmentation","volume":"24","author":"Tobin","year":"2011","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.autrev.2024.103515_bb0315","first-page":"1037","article-title":"Altered protein localization in melanocytes from Hermansky-Pudlak syndrome: support for the role of the HPS gene product in intracellular trafficking","volume":"78","author":"Boissy","year":"1998","journal-title":"Lab Invest"},{"key":"10.1016\/j.autrev.2024.103515_bb0320","first-page":"1","article-title":"The Smyth line chicken: a model for autoimmune amelanosis","volume":"2","author":"Smyth","year":"1989","journal-title":"Crit Rev Poult Biol"},{"key":"10.1016\/j.autrev.2024.103515_bb0325","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/pcmr.12485","article-title":"Water Buffalo (Bubalus bubalis) as a spontaneous animal model of vitiligo","volume":"29","author":"Singh","year":"2016","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.autrev.2024.103515_bb0330","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s12917-021-03046-x","article-title":"Equine vitiligo-like depigmentation in grey horses is related to genes involved in immune response and tumor metastasis","volume":"17","author":"Druml","year":"2021","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.autrev.2024.103515_bb0335","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0165-2427(94)90133-3","article-title":"Sinclair miniature swine: an animal model of human melanoma","volume":"43","author":"Misfeldt","year":"1994","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.autrev.2024.103515_bb0340","first-page":"1065","article-title":"Role of antioxidants in the survival of normal and vitiliginous avian melanocytes","volume":"45","author":"Bowers","year":"1999","journal-title":"Cell Mol Biol (Noisy-le-Grand)"},{"key":"10.1016\/j.autrev.2024.103515_bb0345","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1600-0749.1999.tb00512.x","article-title":"Microphthalmia-associated transcription factor (MITF) locus lacks linkage to human vitiligo or osteopetrosis: an evaluation","volume":"12","author":"Tripathi","year":"1999","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.autrev.2024.103515_bb0350","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0090-1229(92)90188-T","article-title":"The detection of melanocyte autoantibodies in the Smyth chicken model for vitiligo","volume":"64","author":"Austin","year":"1992","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.autrev.2024.103515_bb0355","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/1523-1747.ep12284190","article-title":"Delayed-amelanotic (DAM or Smyth) chicken: melanocyte dysfunction in vivo and in vitro","volume":"86","author":"Boissy","year":"1986","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2024.103515_bb0360","first-page":"197","article-title":"Progressive cytologic changes during the development of delayed feather amelanosis and associated choroidal defects in the DAM chicken line. A vitiligo model","volume":"111","author":"Boissy","year":"1983","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2024.103515_bb0365","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1006\/clin.1995.1105","article-title":"T cells in regenerating feathers of Smyth line chickens with vitiligo","volume":"76","author":"Erf","year":"1995","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.autrev.2024.103515_bb0370","first-page":"1529","article-title":"Mammalian tyrosinase-related protein-1 is recognized by autoantibodies from vitiliginous Smyth chickens. An avian model for human vitiligo","volume":"146","author":"Austin","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2024.103515_bb0375","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/08916939708994728","article-title":"Profiles of pulp infiltrating lymphocytes at various times throughout feather regeneration in Smyth line chickens with vitiligo","volume":"25","author":"Shresta","year":"1997","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2024.103515_bb0380","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/jid.2011.377","article-title":"IFN-\u03b3, IL-21, and IL-10 co-expression in evolving autoimmune vitiligo lesions of Smyth line chickens","volume":"132","author":"Shi","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2024.103515_bb0385","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3382\/ps.0750351","article-title":"Alterations in blood leukocyte populations in Smyth line chickens with autoimmune vitiligo","volume":"75","author":"Erf","year":"1996","journal-title":"Poult Sci"},{"key":"10.1016\/j.autrev.2024.103515_bb0390","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1034\/j.1600-0749.2001.140107.x","article-title":"Herpesvirus connection in the expression of autoimmune vitiligo in Smyth line chickens","volume":"14","author":"Erf","year":"2001","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.autrev.2024.103515_bb0395","series-title":"Chapter 18 - autoimmune diseases of poultry","first-page":"315","author":"Erf","year":"2014"},{"key":"10.1016\/j.autrev.2024.103515_bb0400","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1186\/1471-2164-15-707","article-title":"Genome resequencing and bioinformatic analysis of SNP containing candidate genes in the autoimmune vitiligo Smyth line chicken model","volume":"15","author":"Jang","year":"2014","journal-title":"BMC Genomics"},{"key":"10.1016\/j.autrev.2024.103515_bb0405","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.2353\/ajpath.2006.050769","article-title":"A role for tyrosinase-related protein 1 in 4-tert-butylphenol-induced toxicity in melanocytes: implications for vitiligo","volume":"169","author":"Manga","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2024.103515_bb0410","series-title":"A role of environmental components in autoimmune vitiligo of Smyth line chickens","author":"Dong","year":"2012"},{"key":"10.1016\/j.autrev.2024.103515_bb0415","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-0749.1993.tb00577.x","article-title":"Vitiligo in two water buffaloes: histological, histochemical, and ultrastructural investigations","volume":"6","author":"Cerundolo","year":"1993","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.autrev.2024.103515_bb0420","first-page":"130","article-title":"Melanoma: Sinclair swine melanoma","volume":"108","author":"Hook","year":"1982","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2024.103515_bb0425","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/1523-1747.ep12524353","article-title":"A mouse model for vitiligo","volume":"87","author":"Lerner","year":"1986","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2024.103515_bb0430","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/oxfordjournals.jhered.a111247","article-title":"The vit gene maps to the mi (microphthalmia) locus of the laboratory mouse","volume":"83","author":"Lamoreux","year":"1992","journal-title":"J Hered"},{"key":"10.1016\/j.autrev.2024.103515_bb0435","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/hmg\/4.11.2131","article-title":"The mutational spectrum in Waardenburg syndrome","volume":"4","author":"Tassabehji","year":"1995","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.autrev.2024.103515_bb0440","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12917-019-2003-9","article-title":"Autoimmune diseases affecting skin melanocytes in dogs, cats and horses: vitiligo and the uveodermatological syndrome: a comprehensive review","volume":"15","author":"Tham","year":"2019","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.autrev.2024.103515_bb0445","doi-asserted-by":"crossref","first-page":"242","DOI":"10.30802\/AALAS-CM-22-000091","article-title":"Spontaneous vitiligo in a captive Rhesus monkey (Macaca mulatta)","volume":"73","author":"Meireles","year":"2023","journal-title":"Comp Med"},{"key":"10.1016\/j.autrev.2024.103515_bb0450","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.4049\/jimmunol.0902778","article-title":"Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice","volume":"184","author":"Gregg","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2024.103515_bb0455","doi-asserted-by":"crossref","DOI":"10.1002\/cpim.63","article-title":"Mouse model for human vitiligo","volume":"124","author":"Riding","year":"2019","journal-title":"Curr Protoc Immunol"},{"key":"10.1016\/j.autrev.2024.103515_bb0460","first-page":"3","article-title":"Research status of vitiligo models","author":"Zhao","year":"2022","journal-title":"J Clin Images Med Case Rep"},{"key":"10.1016\/j.autrev.2024.103515_bb0465","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1073\/pnas.96.6.2982","article-title":"Vaccination with a recombinant vaccinia virus encoding a \u201cself\u201d antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes","volume":"96","author":"Overwijk","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2024.103515_bb0470","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.4049\/jimmunol.1103271","article-title":"A coreceptor-independent transgenic human TCR mediates anti-tumor and anti-self immunity in mice","volume":"189","author":"Mehrotra","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2024.103515_bb0475","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1182\/blood-2007-11-120998","article-title":"Tumor-specific Th17-polarized cells eradicate large established melanoma","volume":"112","author":"Muranski","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2024.103515_bb0480","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1084\/jem.190.11.1717","article-title":"Coupling and uncoupling of tumor immunity and autoimmunity","volume":"190","author":"Bowne","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2024.103515_bb0485","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1755-148X.2011.00916.x","article-title":"HSP70i is a critical component of the immune response leading to vitiligo","volume":"25","author":"Mosenson","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.autrev.2024.103515_bb0490","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1172\/JCI44849","article-title":"Autoimmune melanocyte destruction is required for robust CD8+ memory T cell responses to mouse melanoma","volume":"121","author":"Byrne","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2024.103515_bb0495","doi-asserted-by":"crossref","first-page":"223ra23","DOI":"10.1126\/scitranslmed.3007811","article-title":"CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo","volume":"6","author":"Rashighi","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.autrev.2024.103515_bb0500","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jdermsci.2020.06.004","article-title":"Chemical induced pathognomonic features observed in human vitiligo are mediated through miR-2909 RNomics pathway","volume":"100","author":"Kaushik","year":"2020","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.autrev.2024.103515_bb0505","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/exd.12184","article-title":"A mouse model of vitiligo induced by monobenzone","volume":"22","author":"Zhu","year":"2013","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.autrev.2024.103515_bb0510","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/exd.13350","article-title":"The nuclear factor (erythroid-derived 2)-like 2 (NRF2) antioxidant response promotes melanocyte viability and reduces toxicity of the vitiligo-inducing phenol monobenzone","volume":"26","author":"Arowojolu","year":"2017","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.autrev.2024.103515_bb0515","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.2147\/DDDT.S336066","article-title":"Methylcobalamin protects melanocytes from H(2)O(2)-induced oxidative stress by activating the Nrf2\/HO-1 pathway","volume":"15","author":"An","year":"2021","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.autrev.2024.103515_bb0520","doi-asserted-by":"crossref","first-page":"8498472","DOI":"10.1155\/2022\/8498472","article-title":"The role of oxidative stress in the pathogenesis of vitiligo: a culprit for melanocyte death","volume":"2022","author":"Xuan","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.autrev.2024.103515_bb0525","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jdermsci.2009.06.003","article-title":"Effects of hydroquinone and its glucoside derivatives on melanogenesis and antioxidation: biosafety as skin whitening agents","volume":"55","author":"Hu","year":"2009","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.autrev.2024.103515_bb0530","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/ptr.5161","article-title":"The effects of galangin on a mouse model of vitiligo induced by hydroquinone","volume":"28","author":"Huo","year":"2014","journal-title":"Phytother Res"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997224000028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997224000028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T17:24:27Z","timestamp":1715361867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997224000028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":106,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1568997224000028"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2024.103515","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Animal models unraveling the complexity of vitiligo pathogenesis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2024.103515","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103515"}}